Skip to main content
. Author manuscript; available in PMC: 2008 May 5.
Published in final edited form as: J Clin Oncol. 2004 Oct 13;22(22):4463–4473. doi: 10.1200/JCO.2004.11.035

Fig 1.

Fig 1

Mean peripheral-blood lymphocyte count (cell number per mcL ± SE) for (A) the 31 patients completing course 1 and (B) the 12 patients completing both courses at the same dose level. In A, values after d1 are different from pretreatment (P < .0001). Significant differences in B are shown (course 2 v course 1). (*), P < .05; (**), P < .01.